HOXA9 and acute myeloid leukemia: The same MLL-mAf4 construct developed AML when transduced into mouse HSPCs, which characteristically expressed Hoxa9 and Meis1, suggesting that human HSPCs are prone to developing pro-B ALL compared to mouse HSPCs.